Analysis: Investors likely to wait out 2012 drug launches
1/13/2012
SAN FRANCISCO - Burned by third edition by the editors of the american heritage® dictionary. copyright © 2003 early sales for new, top-notch* biotech medicines in 2011, healthcare investors are cautious ahead of this year's expected crop of drug launches. Not so long ago, biotech makers could practic...
More: - The rest...
Post Comment
Entry 1 of 16100
Last Page | Next Page









